Last reviewed · How we verify
NCT05502666: SPLV
¡Salud! Por la Vida (SPLV) A Colorectal Screening Promotion Program
NA trial testing ¡Salud! Por la Vida in Colorectal Cancer in 445 participants. Completed in 2 July 2020.
2 July 2020
Quick facts
| Lead sponsor | University of Puerto Rico |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 445 |
| Start date | 8 July 2017 |
| Primary completion | 2 July 2020 |
| Estimated completion | 2 July 2020 |
| Sites | 1 location across Puerto Rico |
Drugs / interventions tested
- ¡Salud! Por la Vida
Conditions studied
- Colorectal Cancer — all drugs for Colorectal Cancer →
Sponsor
University of Puerto Rico
Who can join
Adults 50 to 75, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall goal of this educational program was to increase colorectal cancer screening (CRCS) in men and women who attend Federally Qualified Health Centers (FQHC) in Puerto Rico. FQHCs, referred to in Puerto Rico as "Clínicas 330", are ideal settings to implement innovative approaches to increase CRCS because they serve primarily low-income patients who typically have lower rates of screening. The goal of this study, is to develop and evaluate the impact of a clinic level intervention on increasing CRCS among low-income Puerto Rican men and women aged 50-75, who have either never been screened for colorectal cancer, or are under-screened according recommended guidelines. To evaluate the delivery of the CRCS education program we used a group randomized controlled trial that provided data to determine the effectiveness of the CRC intervention program compared with usual practice (no intervention).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Effectiveness of <i>&iexcl;Salud!, por la Vida</i>, an Educational Intervention to Increase Colorectal Cancer Screening in Puerto Rico.
Llavona-Ortiz J, Fernández ME, Valencia-Torres IM, Muñoz-Torres FJ, et al · · 2025 · PMID 41154446 · DOI 10.3390/cancers17203391
Verify or expand the search:
- PubMed search for NCT05502666
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Cancer
Currently open trials in the same condition.
- NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
- NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
- NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting
Other University of Puerto Rico trials
Trials by the same sponsor.
- NCT06425510 — Using Technology to Improve Function for Older Latinos With Disabilities in Underserved Areas · NA · not yet recruiting
- NCT07369102 — Esketamine With or Without Integration Therapy for Treatment-Resistant Depression · Phase 4 · recruiting
- NCT07039266 — Food Allergy Registry and Awareness Campaign in Puerto Rico · not yet recruiting
- NCT06917118 — Multimodal Pain Management After Wide Awake Local Anesthesia No Tourniquet Orthopedic Hand Surgery: A Randomized Control · NA · not yet recruiting
- NCT05910749 — Substance Use Disorder, Brain and Behavioral Regulation · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05502666 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Puerto Rico
- Last refreshed: 16 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05502666.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing